CME Group Inc. $CME Shares Acquired by Strs Ohio

Strs Ohio grew its stake in CME Group Inc. (NASDAQ:CME) by 15.8% during the 2nd quarter, Holdings Channel reports. The firm owned 127,043 shares of the financial services provider’s stock after purchasing an additional 17,319 shares during the quarter. Strs Ohio’s holdings in CME Group were worth $35,016,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Golden State Wealth Management LLC boosted its stake in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 98 shares during the last quarter. Mather Group LLC. boosted its stake in CME Group by 30.2% during the 1st quarter. Mather Group LLC. now owns 1,873 shares of the financial services provider’s stock worth $497,000 after purchasing an additional 434 shares during the last quarter. Cidel Asset Management Inc. acquired a new stake in CME Group during the 1st quarter worth $240,000. Rossby Financial LCC acquired a new stake in CME Group during the 1st quarter worth $61,000. Finally, FSM Wealth Advisors LLC acquired a new stake in CME Group during the 1st quarter worth $260,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Performance

NASDAQ:CME opened at $262.89 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $94.74 billion, a price-to-earnings ratio of 25.47, a PEG ratio of 4.41 and a beta of 0.41. The company’s 50-day moving average is $265.91 and its two-hundred day moving average is $272.01. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the firm posted $2.68 earnings per share. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. Analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is 48.45%.

Insiders Place Their Bets

In related news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. The trade was a 4.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 over the last 90 days. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. UBS Group lowered their price target on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research report on Thursday, October 23rd. JPMorgan Chase & Co. boosted their target price on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a report on Tuesday, October 14th. Morgan Stanley boosted their target price on CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. Finally, The Goldman Sachs Group boosted their target price on CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a report on Thursday, October 23rd. Eight analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $284.53.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.